Bio-Reference Laboratories Inc.
481 Edward H Ross Drive
Elmwood Park,
NJ 07407
United States - Map
Phone: 201-791-2600
Fax: 201-791-1941
Website: http://www.bioreference.com
Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area. The company offers chemical diagnostic tests, such as blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology, and other tissue analysis, as well as performs cancer cytogenetic testing. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, womens health, and correctional health care services. In addition, the company operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data and other data sources to provide administrative and clinical decision support systems; and a Web-based connectivity portal solution for laboratories and physicians. Bio-Reference Laboratories, Inc. provides its services directly to physicians, geneticists, hospitals, clinics, and correctional and other health facilities. The company was founded in 1981 and is based in Elmwood Park, New Jersey. Key Statistics
| |
| Bio-Reference Laboratories Inc.’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Medium Concern), Board (High Concern), Compensation (High Concern), Shareholder Rights (Medium Concern). | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Dr. Marc D. Grodman M.D.,
60
Founder, Chairman, Chief Exec. Officer and Pres | 2.67M | 0.00 | Mr. Sam Singer ,
68
Chief Financial Officer, Chief Accounting Officer, Sr. VP and Director | 598.00K | 0.00 | Mr. Howard Dubinett ,
60
Chief Operating Officer, Exec. VP and Director | 488.00K | 0.00 | Dr. John Roglieri M.D.,
72
Director, Chairman of Compensation Committee, Chairman of Nominating Committee and Member of Audit Committee | 80.00K | 0.00 | Dr. James Weisberger M.D.,
56
Chief Medical Officer and Sr. VP | N/A | N/A |
|
| | Amounts are as of Dec 30, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.60% Nasdaq 
0.04(0.20%) May 25, 4:00PM EDT|After Hours:
20.38 0.00 (0.00%) May 25, 4:48PM EDT